Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
May-2014 Volume 7 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2014 Volume 7 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Mechanisms of ischemic stroke in patients with intracranial atherosclerosis: A high‑resolution magnetic resonance imaging study

  • Authors:
    • Tianli Gao
    • Wei Yu
    • Chunjie Liu
  • View Affiliations / Copyright

    Affiliations: Department of Neurology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, P.R. China, Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, P.R. China
  • Pages: 1415-1419
    |
    Published online on: March 4, 2014
       https://doi.org/10.3892/etm.2014.1600
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

High‑resolution magnetic resonance imaging (HRMRI) has a unique ability to provide an evaluation of the intracranial artery wall. This study aimed to investigate the possible mechanisms of ischemic stroke in patients with intracranial atherosclerosis using HRMRI. HRMRI was performed on 55 patients (38 male and 17 female) with acute cerebral infarction to investigate the lumen‑intruding plaque at the stenotic portion of the middle cerebral artery (MCA) and basilar artery (BA) and to attempt to identify the mechanisms of stroke. Penetrating artery disease (PAD) was diagnosed in 20 patients (36%) and large‑artery atherosclerosis (LAA) was diagnosed in 35 patients, including 19 with parent artery plaques occluding a penetrating artery (POPA; 35%) and 16 with artery‑to‑artery embolisms (29%). Patients with PAD had a higher frequency of hypertension compared with that of the patients with LAA (80 versus 29%; P<0.001), and patients with LAA had a higher frequency of diabetes compared with that of the patients with PAD (40% versus 15%; P=0.054). Magnetic resonance angiography revealed mild to moderate stenosis in the patients with POPA, while border zone infarction and artery‑to‑artery embolism occurred in the majority of the patients with severe stenosis or occlusion of the MCA and BA. HRMRI has the ability to identify the mechanisms of intracranial atherosclerotic ischemic stroke through the detection of luminal plaques.

Introduction

Atherosclerosis of the intracranial arteries is frequent and may account for almost one-third of ischemic strokes in the Chinese population (1,2). The underlying mechanisms of cerebral infarction include artery-to-artery embolism, hemodynamic compromise, local branch occlusion or a combination of those conditions (3). Clique histological study of the middle cerebral artery (MCA) has demonstrated that luminal stenosis is frequently caused by ruptured vulnerable plaques, which are characterized by their specific morphology and composition, which comprises a large lipid/necrotic core covered by a thin fibrous cap infiltrated by macrophages and intraplaque hemorrhage (4). Each clique corresponds to a pair of neighboring pixels, and the clique potential is designed to favor similar classes in neighboring pixels. Progression and a greater extent of intracranial atherosclerosis imply a higher risk of recurrence (5).

High-resolution magnetic resonance imaging (HRMRI) has a unique ability to provide information on plaque composition comparable to that obtained by histology (6). Several studies have confirmed the feasibility of using HRMRI to evaluate the intracranial artery wall and have identified the presence of arterial plaques using HRMRI, in cases where magnetic resonance angiography (MRA) showed no lumen abnormality (7–9). In the present study, HRMRI was used to identify the ischemic stroke subtypes of patients with intracranial atherosclerosis and to investigate the possible mechanisms.

Material and methods

Study population

A single-center, prospective trial was conducted in the Neurology Department of Beijing Anzhen Hospital, Capital Medical University (Beijing, China) between January 2010 and January 2013. A total of 55 patients with acute cerebral infarction were screened and were subsequently tested for ≥50% MCA and basilar artery (BA) stenosis by cranial MRI and MRA. The ischemic stroke in these patients was presumed to be caused by atherosclerotic disease. Inclusion criteria were as follows: i) unilateral middle cerebral artery stenosis (≥70%) or occlusion due to atherosclerosis were observed while no ipsilateral internal carotid artery stenosis or occlusion could be found; ii) there was infarcted focus within corresponding stenosed artery on MRI. iii) Patients must have at least one of the risk factors for atherosclerosis, including hypertension, diabetes, hyperlipidemia, homocysteine and smoking. Exclusion criteria included: i) patients with ipsilateral internal carotid artery stenosis or occlusion. ii) Non-atherosclerotic cerebral artery stenosis, such as fibromuscular dysplasia, arteritis and dissecting aneurysm. iii) Patients suspected to have symptoms of cardiogenic embolism, including recent myocardial infarction, atrial fibrillation with or without mural thrombus, mitral stenosis or prosthetic valve, dilated cardiomyopathy, sick sinus syndrome, acute bacterial endocarditis and patent foramen ovale. Written informed consent was obtained from all patients. The Ethical Committee of Beijing Anzhen Hospital approved this study (Beijing, China).

Clinical assessment

All patients underwent a detailed medical history assessment and a physical examination at baseline that included routine blood biochemistry tests, coagulation testing, transthoracic or transesophageal echocardiography, Holter electrocardiography, transcranial Doppler sonography, carotid ultrasound, and computed tomography, MRI and MRA of the brain. Data collected from patients included the following baseline characteristics: Age, gender, vascular risk factors, such as hypertension or history of hypertension or its complications, history of diabetes mellitus (DM) or currently diagnosed DM, hyperlipidemia, history of smoking, previous coronary artery disease and previous cerebrovascular disease.

Ischemic stroke subclassification

According to the Chinese ischemic stroke subclassification (10), the patients were grouped into two mechanism-based categories: Penetrating artery disease (PAD; no evidence of atherosclerotic plaques or any degree of stenosis in the parent artery) and large-artery atherosclerosis (LAA; plaques in the parent artery occluding a penetrating artery, artery-to-artery embolism or hypoperfusion/impaired emboli clearance).

MRI protocol and review

All patients were imaged at the Beijing Anzhen Hospital using a Magnetom Verio 3T MRI scanner (Siemens AG, Erlangen, Germany) and an eight-channel brain-array coil. A standardized protocol was used to perform conventional brain T1- and T2-weighted MRI and three-dimensional (3D) time-of-flight (TOF)-MRA. 3D TOF-MRA data were obtained using an axial plane with a repetition time (TR)/echo time (TE) of 21 msec/3.6 msec; flip angle of 18°; field-of-view (FOV) of 220×220 mm; slice thickness of 0.5 mm; and a matrix size of 320×380 pixels. The TOF-MRA scan time was 4 min. MRA data were reconstructed using a dedicated online post-processing tool [multiplanner reconstruction (MPR), maximum intensity (MIP), volume rendering (VR)] to determine the blood vessel architecture.

HRMRI data were acquired from the patients with MCA and BA steno-occlusive lesions along the short axes of the stenotic segments on TOF-MRA images. The lesion site for the evaluation of unilateral MCA stenosis was determined by the interpreting neuroradiologist as the ipsilateral MCA in the symptomatic patients and the side of severe MCA stenosis in the asymptomatic patients. T1- and T2-weighted MRI was centered at the stenosis of the MCA-M1 segment, vertebral artery, BA and their confluences. The MRI parameters were: T1-weighted, double inversion recovery, black blood, two-dimensional turbo spin echo (TSE), TR/TE = 920 msec/27 msec, FOV = 120×120 mm, matrix size = 270×320 pixels, slice thickness = 2.0 mm and 2NEX. For the T2-weighted HRMRI scans, the TSE sequence used a TR/TE of 2,350 msec/78 msec, FOV of 120×120 mm, matrix size of 270×320 pixels, slice thickness of 2.0 mm and 2NEX. The black blood technique with pre-regional saturation pulses of 80- mm thickness to saturate incoming arterial flow was used for the scans. The longitudinal coverage of each artery was 16 mm (eight slices) for the two types of scans, with a scan time of ~3–4 min/scan. The total scan time was ~20 min and the patients remained in the MRI machine for ~30 min.

Statistical analysis

A χ2 test was used to compare frequencies. One-way analysis of variance and Student’s t-test were used for normally distributed variables, whereas the Mann-Whitney U test was used for non-normally distributed variables. All tests of statistical significance were two-sided, with P<0.05 considered to indicate a statistically significant difference. All statistical analyses were performed using SPSS software, version 17.0 (SPSS, Inc., Chicago, IL, USA).

Results

A total of 55 patients who met the eligibility criteria were recruited to this study. There were 38 males and 17 females with a median age of 58.9 years (standard deviation, ±13.4 years; range, 35–81 years). Among the 55 patients, 17 had vertebrobasilar stenosis (31%) and 38 had MCA stenosis (69%). PAD was diagnosed in 20 of the patients (36%) and LAA was diagnosed in 35 of the patients, which included 19 with a parent artery plaque occluding a penetrating artery (POPA) (35%) and 16 with artery-to-artery embolism and/or hypoperfusion (29%). The baseline characteristics in the two groups were comparable, with the exceptions that the patients with PAD had a higher frequency of hypertension compared with that of the patients with LAA (80 versus 29%; P<0.001) and the patients with LAA had a higher frequency of DM than that of the patients with PAD (40 versus 15%; P=0.054) (Table I). POPA occurred more frequently in the patients with mild to moderate artery stenosis (63%; P<0.05) than in the patients with severe artery stenosis or occlusion (37%). However, the stroke mechanisms of artery-to-artery embolism and/or hypoperfusion were mainly observed in the patients with severe artery stenosis or occlusion (68%) compared with in the patients with mild to moderate artery stenosis (13.3%; P=0.060).

Table I

Baseline characteristics of patients with PAD and LAA.

Table I

Baseline characteristics of patients with PAD and LAA.

CharacteristicPAD (n=20)LAA (n=35)P-value
Mean age (years; SD, range)62 (14.5, 35–81)58 (12.1, 47–75)0.569
Gender (male/female)13/725/100.619
Hypertension16 (80%)10 (29%)<0.001
DM3 (15%)14 (40%)0.054
Hyperlipidemia4 (20%)6 (17%)0.792
History of smoking8 (40%)13 (37%)0.834
History of CAD5 (25%)9 (26%)0.953
History of CVD3 (15%)7 (20%)0.644

[i] PAD, penetrating artery disease; LAA, large-artery atherosclerosis; DM, diabetes mellitus; CAD, coronary artery disease; CVD, cerebrovascular disease.

HRMRI enabled the detection of the lumen wall, and the MCA and BA were clearly observed in all cases. The cross-sectional imaging findings of patients who were diagnosed with LAA indicated that the presence of focal arterial wall thickening was consistent with a plaque on the level of the MCA and BA stenotic area on MRA images. The plaque appeared as a crescent-shaped or eccentric thickening surrounding a circular lumen. As shown in Fig. 1, in a 72-year-old male patient, MRA revealed relatively mild stenosis in the MCA-M1 segment, while HRMRI showed no lumen abnormality. A high-intensity infarct lesion revealed by diffusion-weighted imaging (DWI) was present in the lateral striate arterial territory, indicating that this was a case of the PAD stroke subtype. HRMRI findings of the lumen elucidated the underlying mechanisms in which lipohyalinosis or microatheroma may be the etiology for PAD. Furthermore, in a 60-year-old female patient, MRA showed relatively mild to moderate stenosis in the BA where an eccentric plaque located in the lumen wall was shown to occlude the paramedian pontine arteries by HRMRI. An acute ischemic infarction was verified by DWI (Fig. 2). This was indicated to be a typical case, where the infarction was confined to the territory of a single branch artery or a few penetrating branches that were occluded by the plaques of their parent arteries. Borderzone infarction and artery-to-artery embolism occurred in the most severe stenosis and occlusion of the MCA and BA. Computed tomography perfusion imaging of a 71-year-old female patient demonstrated relatively low cerebral blood flow and elevated time-to-peak in a region of the MCA, indicating the potential mechanism of hypoperfusion (Fig. 3).

Figure 1

A 72-year-old male presented with left hemiparesis and dysarthria. (A) Right MCA wall MRA indicates mild-grade MCA stenosis. (B) T2-weighted HRMRI cross-sectional image of the MCA (M1 segment) reveals a normal circular lumen with no wall thickening. (C) A single small infarction of a penetrating artery is shown using DWI. (D) T2 fluid-attenuated inversion-recovery imaging indicates an infarction lesion located at the same position, corresponding to the territory of a penetrating artery of the right MCA. The arrows represent the position of the lesion. MCA, middle cerebral artery; HRMRI, high-resolution magnetic resonance imaging; DWI, diffusion-weighted imaging.

Figure 2

A 60-year-old female presented with an episode of sudden onset left face, arm and leg weakness. (A) MRA revealed an irregular mild BA stenosis close to the pontine paramedian artery. (B) An acute high-intensity infarction was demonstrated on the axial DWI image at the level of the right lateral pontine. (C and D) Cross-sectional T1- and T2-weighted HRMRI at the level of the BA revealed a lipid-rich necrotic eccentric plaque with low or iso-signal density. The arrows represent the position of the lesion. MRA, magnetic resonance angiography; BA, basilar artery; DWI, diffusion-weighted imaging; HRMRI, high-resolution magnetic resonance imaging.

Figure 3

A 71-year-old female patient presented with dysarthria and mild left hemiparesis. (A) MRA from the right proximal MCA (M1 segment) showed a focal severe stenosis. (B) DWI confirmed internal border-zone infarction, which corresponded to the right MCA territory with the underlying mechanism of hypoperfusion and impaired emboli clearance. (C) Computed tomography perfusion imaging also demonstrated relatively low cerebral blood flow, and elevated time-to-peak in a region of the right MCA indicated the potential of hypoperfusion. (D) The T2-weighted HRMRI cross-sectional lumen image showed a hyposignal eccentric core surrounded by a high-signal thickened wall. The arrows represent the position of the lesion. MRA, magnetic resonance angiography; MCA, middle cerebral artery; DWI, diffusion-weighted imaging; HRMRI; high-resolution magnetic resonance imaging.

Discussion

Intracranial atherosclerotic disease causes ischemic strokes, and the rates of recurrent vascular ischemic events and vascular mortalities are very high (11). However, intracranial atherosclerosis, which affects cerebral arteries such as the BA and MCA, remains an infradiagnosed and understudied disease (12). The diagnosis of intracranial stenosis is traditionally dependent on conventional angiography and several reliable noninvasive diagnostic methods, including transcranial color-coded duplex sonography, MRA and computed tomography angiography (13,14). Cross-sectional HRMRI is a promising technique for imaging carotid plaques, with a sensitivity of 85% and a specificity of 92% for identifying soft plaques (necrotic core or hemorrhage) (15–17). HRMRI has consistently emerged as a potential technique for imaging atherosclerotic plaques in the intracranial arteries (7). This imaging technique may provide information about the histopathological nature of the intracranial atherosclerotic lesion responsible for arterial narrowing (9).

As no underlying cause is found in >30% of stroke cases, HRMRI detection of intracranial atherosclerotic lesions may have significant clinical implications (3). Detection of the vessel wall of arteries such as the MCA and BA may improve the ability to identify advanced but unrecognized intracranial atherosclerotic disease (18). In the present study, the features of the MCA and BA luminal wall in patients who had suffered cerebral infarction were explored. Recognizing the characteristics of LAA and PAD may contribute to improved risk stratification and allow aggressive interventions to be targeted at patients with plaques that are prone to rupture (19–21). A previous study of carotid artery plaques has demonstrated a significant correlation between plaque characteristics identified by HRMRI and subsequent stroke patterns (19). In the present study, HRMRI clearly confirmed the presence of a reduced arterial lumen associated with a focal wall thickening and plaques at the level of MCA and BA stenosis, suggesting that the HRMRI technique was useful in determining the etiology of PAD and POPA.

In a comparison of the patients with PAD and those with LAA, it was observed that patients with PAD had a higher frequency of hypertension whereas patients with LAA had a higher frequency of DM. Aging and chronic hypertension are risk factors for large-artery atherosclerosis (22). Such changes include replacement of the smooth muscle cells by fibro-hyaline material with thickening of the wall and narrowing of the vascular lumen. Arteriolosclerosis may be one of the reasons that the blood supply to the white matter is altered, and this vascular change may lead to localized ischemic areas of necrosis and cavitations (14). Previous studies have shown a high frequency of intracranial stenosis in diabetic Caucasian patients, an independent association of type II DM to a greater extent of intracranial LAA, and a significantly higher number of diseased vessels in diabetic patients compared with that in nondiabetic patients (13,23). The association between diabetes and more diffuse and advanced intracranial atherosclerosis is unclear. Consequently, among the traditional vascular risk factors, diabetes appears to play a preeminent role in intracranial macroangiopathy in the Chinese population (24). Additionally, the presence of intracranial LAA disease contributes to a poorer outcome for patients with LAA disease, which may be stratified as very high risk in secondary prevention (25).

In conclusion, stroke patterns of intracranial atherosclerotic arteries are complicated and mainly include LAA and PAD. HRMRI has the ability to identify the mechanisms behind intracranial atherosclerotic ischemic stroke by showing the luminal wall. It may also provide a useful tool in risk stratification and the selection of candidates for invasive therapies.

References

1 

Pu Y, Liu L, Wang Y, et al; Chinese IntraCranial AtheroSclerosis (CICAS) Study Group. Geographic and sex difference in the distribution of intracranial atherosclerosis in China. Stroke. 44:2109–2114. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Rincon F, Sacco RL, Kranwinkel G, et al: Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Cerebrovasc Dis. 28:65–71. 2009. View Article : Google Scholar : PubMed/NCBI

3 

Shi MC, Wang SC, Zhou HW, et al: Compensatory remodeling in symptomatic middle cerebral artery atherosclerotic stenosis: a high-resolution MRI and microemboli monitoring study. Neurol Res. 34:153–158. 2012.PubMed/NCBI

4 

Naghavi M, Libby P, Falk E, et al: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 108:1664–1672. 2003. View Article : Google Scholar

5 

Xu WH, Li ML, Gao S, et al: In vivo high-resolution MR imaging of symptomatic and asymptomatic middle cerebral artery atherosclerotic stenosis. Atherosclerosis. 212:507–511. 2010. View Article : Google Scholar : PubMed/NCBI

6 

Ma N, Jiang WJ, Lou X, et al: Arterial remodeling of advanced basilar atherosclerosis: a 3-tesla MRI study. Neurology. 75:253–258. 2010. View Article : Google Scholar : PubMed/NCBI

7 

Bodle JD, Feldmann E, Swartz RH, Rumboldt Z, Brown T and Turan TN: High-resolution magnetic resonance imaging: an emerging tool for evaluating intracranial arterial disease. Stroke. 44:287–292. 2013. View Article : Google Scholar : PubMed/NCBI

8 

Niizuma K, Shimizu H, Takada S and Tominaga T: Middle cerebral artery plaque imaging using 3-Tesla high-resolution MRI. J Clin Neurosci. 15:1137–1141. 2008. View Article : Google Scholar : PubMed/NCBI

9 

Ryu CW, Jahng GH, Kim EJ, Choi WS and Yang DM: High resolution wall and lumen MRI of the middle cerebral arteries at 3 tesla. Cerebrovasc Dis. 27:433–442. 2009. View Article : Google Scholar : PubMed/NCBI

10 

Gao S, Wang YJ, Xu AD, et al: Chinese ischemic stroke subclassification. Front Neurol. 2:62011.

11 

Turan TN, Maidan L, Cotsonis G, et al; Warfarin-Aspirin Symptomatic Intracranial Disease Investigators. Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke. 40:505–509. 2009. View Article : Google Scholar : PubMed/NCBI

12 

Kim JM, Jung KH, Sohn CH, Moon J, Han MH and Roh JK: Middle cerebral artery plaque and prediction of the infarction pattern. Arch Neurol. 69:1470–1475. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Arenillas JF and Alvarez-Sabin J: Basic mechanisms in intracranial large-artery atherosclerosis: advances and challenges. Cerebrovasc Dis. 20(Suppl 2): 75–83. 2005. View Article : Google Scholar : PubMed/NCBI

14 

Yazdani SK, Vorpahl M, Ladich E and Virmani R: Pathology and vulnerability of atherosclerotic plaque: identification, treatment options, and individual patient differences for prevention of stroke. Curr Treat Options Cardiovasc Med. 12:297–314. 2010. View Article : Google Scholar

15 

Cai JM, Hatsukami TS, Ferguson MS, Small R, Polissar NL and Yuan C: Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 106:1368–1373. 2002. View Article : Google Scholar : PubMed/NCBI

16 

Kampschulte A, Ferguson MS, Kerwin WS, et al: Differentiation of intraplaque versus juxtaluminal hemorrhage/thrombus in advanced human carotid atherosclerotic lesions by in vivo magnetic resonance imaging. Circulation. 110:3239–3244. 2004. View Article : Google Scholar

17 

Larose E, Yeghiazarians Y, Libby P, et al: Characterization of human atherosclerotic plaques by intravascular magnetic resonance imaging. Circulation. 112:2324–2331. 2005. View Article : Google Scholar : PubMed/NCBI

18 

Lam WW, Wong KS, So NM, Yeung TK and Gao S: Plaque volume measurement by magnetic resonance imaging as an index of remodeling of middle cerebral artery: correlation with transcranial color Doppler and magnetic resonance angiography. Cerebrovasc Dis. 17:166–169. 2004.

19 

Gao T, Zhang Z, Yu W, Zhang Z and Wang Y: Atherosclerotic carotid vulnerable plaque and subsequent stroke: a high-resolution MRI study. Cerebrovasc Dis. 27:345–352. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Mono ML, Karameshev A, Slotboom J, et al: Plaque characteristics of asymptomatic carotid stenosis and risk of stroke. Cerebrovasc Dis. 34:343–350. 2012. View Article : Google Scholar : PubMed/NCBI

21 

Lindsay AC, Biasiolli L, Lee JM, et al: Plaque features associated with increased cerebral infarction after minor stroke and TIA: a prospective, case-control, 3-T carotid artery MR imaging study. JACC Cardiovasc Imaging. 5:388–396. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Pantoni L and Garcia JH: Pathogenesis of leukoaraiosis: a review. Stroke. 28:652–659. 1997. View Article : Google Scholar : PubMed/NCBI

23 

Arenillas JF, Molina CA, Chacón P, et al: High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology. 63:27–32. 2004. View Article : Google Scholar : PubMed/NCBI

24 

Thomas GN, Lin JW, Lam WW, et al: Albuminuria is a marker of increasing intracranial and extracranial vascular involvement in Type 2 diabetic Chinese patients. Diabetologia. 47:1528–1534. 2004. View Article : Google Scholar : PubMed/NCBI

25 

Kwan MW, Mak W, Cheung RT and Ho SL: Ischemic stroke related to intracranial branch atheromatous disease and comparison with large and small artery diseases. J Neurol Sci. 303:80–84. 2011. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Gao T, Yu W and Liu C: Mechanisms of ischemic stroke in patients with intracranial atherosclerosis: A high‑resolution magnetic resonance imaging study. Exp Ther Med 7: 1415-1419, 2014.
APA
Gao, T., Yu, W., & Liu, C. (2014). Mechanisms of ischemic stroke in patients with intracranial atherosclerosis: A high‑resolution magnetic resonance imaging study. Experimental and Therapeutic Medicine, 7, 1415-1419. https://doi.org/10.3892/etm.2014.1600
MLA
Gao, T., Yu, W., Liu, C."Mechanisms of ischemic stroke in patients with intracranial atherosclerosis: A high‑resolution magnetic resonance imaging study". Experimental and Therapeutic Medicine 7.5 (2014): 1415-1419.
Chicago
Gao, T., Yu, W., Liu, C."Mechanisms of ischemic stroke in patients with intracranial atherosclerosis: A high‑resolution magnetic resonance imaging study". Experimental and Therapeutic Medicine 7, no. 5 (2014): 1415-1419. https://doi.org/10.3892/etm.2014.1600
Copy and paste a formatted citation
x
Spandidos Publications style
Gao T, Yu W and Liu C: Mechanisms of ischemic stroke in patients with intracranial atherosclerosis: A high‑resolution magnetic resonance imaging study. Exp Ther Med 7: 1415-1419, 2014.
APA
Gao, T., Yu, W., & Liu, C. (2014). Mechanisms of ischemic stroke in patients with intracranial atherosclerosis: A high‑resolution magnetic resonance imaging study. Experimental and Therapeutic Medicine, 7, 1415-1419. https://doi.org/10.3892/etm.2014.1600
MLA
Gao, T., Yu, W., Liu, C."Mechanisms of ischemic stroke in patients with intracranial atherosclerosis: A high‑resolution magnetic resonance imaging study". Experimental and Therapeutic Medicine 7.5 (2014): 1415-1419.
Chicago
Gao, T., Yu, W., Liu, C."Mechanisms of ischemic stroke in patients with intracranial atherosclerosis: A high‑resolution magnetic resonance imaging study". Experimental and Therapeutic Medicine 7, no. 5 (2014): 1415-1419. https://doi.org/10.3892/etm.2014.1600
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team